Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01031264 · ClinicalTrials.gov registry record

Chronic Alcohol and Brain Stress Circuit Response

A clinical trial of Stress and Alcoholism, sponsored by Yale University.

Completed
Registry status
120
Enrollment target
1
Study location

NCT01031264 is a study of Stress and Alcoholism that has completed, run by Yale University. The registered enrollment target is 120 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01031264, a study of Stress and Alcoholism, has completed, sponsored by Yale University.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

Alcoholism is among the top three causes of preventable death and disease in the US (Mokdad et al., 2004; Room et al., 2005). Stress plays an important role in the development of alcoholism and in high vulnerability to alcohol relapse. This study will provide a greater understanding of the mechanism by which stress and alcohol consumption interacts to influence development of compulsive alcohol seeking and vulnerability to stress-induced drinking, and the results will have significant implications for the development of new prevention and treatment interventions for alcoholism.

Conditions Studied

Study Locations (1)

Connecticut

  • Yale Stress Center - New Haven

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-01
Est. Completion 2014-12

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01031264

The ClinicalTrials.gov registry entry for NCT01031264 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 152 other Stress trials with a reported enrollment target (85% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 0 interventions.

NCT01031264 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01031264 about?

NCT01031264 is a clinical study titled "Chronic Alcohol and Brain Stress Circuit Response". Alcoholism is among the top three causes of preventable death and disease in the US (Mokdad et al., 2004; Room et al., 2005). Stress plays an important role in the development of alcoholism and in high vulnerability to alcohol relapse. This study will provide a greater understanding of the mechanism...

What is the current status of trial NCT01031264?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2009-01. Estimated completion is 2014-12.

What conditions does trial NCT01031264 study?

This clinical trial studies the following conditions: Stress, Alcoholism.

Who is sponsoring clinical trial NCT01031264?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01031264 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.